Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from FDA

FDA Updates Hormone Therapy Labels: What Changed for 6 Menopause Meds

Opening your mailbox or picking up a prescription shouldn’t feel like a guessing game about your safety. If you are navigating menopause, you likely rely on hormone replacement therapy for symptom relief. However, the information provided when you first started your journey may now be outdated. The FDA has mandated…

Budget and the Bees

Parental Rights Not to Have School Hide Child's Social Gender Transition / Parental Rights to Provide Child with Surgical or Hormonal Gender Transition

Today's unsigned majority opinion in Mirabelli v. Bonta held that California policies that "prevent schools from telling them about their… The post Parental Rights Not to Have School Hide Child's Social Gender Transition / Parental Rights to Provide Child with Surgical or Hormonal Gender Transition appeared first on Reason.com.

Reason

FDA Issues Highest ‘Class I’ Warning: 60,000 Lbs of Frozen Blueberries Recalled for Listeria Risk

Opening a freezer to grab fruit for a smoothie should be a healthy choice. For many people, however, that simple act currently carries a hidden danger. Federal regulators recently upgraded a massive recall to a Class I warning. This represents the highest risk level the FDA issues. Such a classification…

Budget and the Bees

From analysis to the latest developments in health,
read the most diverse news in one place.

The recall of the honey barbecue sauce was issued after a mislabeling issue was discovered

The Independent UK

Ozempic vs Mounjaro: Comparing GLP‑1 Injectable Weight‑Loss Meds, Semaglutide vs Tirzepatide, and Real Side Effects

Discover how Ozempic vs Mounjaro compare as GLP‑1 injectable weight‑loss meds, exploring semaglutide vs tirzepatide differences, effectiveness, and common Ozempic side effects.

Medical Daily

Drug company ads are easy to blame for misleading patients and raising costs, but research shows they do help patients get needed treatment

It’s a familiar experience for many Americans: You’re watching your favorite show and suddenly you’re ambushed by an ad for a drug whose name sounds like a Wi-Fi password, before a relentlessly cheerful voice tells you to “Ask your doctor” and then blasts through a side-effect list that’s laughably long.

The Conversation

FDA recalls chocolate syrup over unlisted Viagra ingredient

IN FULL

The Independent UK

Read news from The Economist, FT, and more,
with one subscription

Nationwide recall issued for ‘Boner Bears’ chocolate syrup containing undeclared Viagra ingredient

The sexual enhancement product was recalled after an FDA laboratory analysis confirmed it contained an undeclared Viagra ingredient

The Independent UK

FDA to offer bonus payments to staffers who complete speedy drug reviews

The head of the Food and Drug Administration plans to start offering bonus payments to agency drug reviewers who complete their work ahead of the schedule

The Independent UK

Medicare Will Now Cover Wegovy for Heart Disease Patients — Here’s What the New Policy Actually Means

Medicare has changed its stance on GLP-1 drugs like Wegovy, moving into 2026. While it is known for its weight loss effects, Medicare Part D...

Saving Advice

Ayahuasca psychedelic DMT shows promise as depression therapy

Study finds participants saw reduction in depressive symptoms as researchers welcome ‘promising’ results

The Guardian - US

FDA takes down page warning of crank autism cures as RFK Jr. nominates people have promoted them

Robert F KennedyJr says his new appointees will help him ‘fight autism.’ But, Eric Garcia writes, many of them also contributed to his presidential campaign

The Independent UK

FDA proposes new system for approving customized drugs and therapies for rare diseases

The Food and Drug Administration is proposing a system for approving customized drugs and medical treatments for patients with rare or hard-to-treat diseases

The Independent UK

Magic Mushrooms, Hard Cash: Compass Pathways’ Trial Win, Fast Raise

See what Compass Pathways’ Phase 3 COMP360 TRD data showed, why the stock jumped, and how a discounted offering reshapes the near-term setup.

MarketBeat

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart

This High-Yield Dividend King Has 56 Years of Raises and Wall Street Is Screaming ‘Buy’

This 56-year Dividend King yields 6.3%, carries a Moderate Buy rating, and could offer steady income plus upside despite industry shifts.

The Conversation

Menstrual pads and tampons can contain toxic substances – here’s what to know about this emerging health issue

About half of the global population menstruates at some point in their lives. Disposable products, such as tampons and pads, are some of the most popular products used around the globe to manage menstrual flow.

The Guardian - US

Anger as Trump FDA retreats from plan to ban artificial colors in food

Experts say new labeling could deceive consumers as dangerous substances still allowed under new rules

Reason

Canada's Government-Dominated Health Care Chokes Access to New Drugs

Price controls and regulatory burdens make the market unattractive for pharmaceutical companies.

Get all your
news in one place.

100's of premium titles.
One news app.

Reason

FDA Commissioner Says 'Everything Should Be Over the Counter.' Don't Count on Big Pharma To Lead the Way.

A system that allows drug makers to profit from restricted access will never liberalize on its own—and patients will continue to bear the cost.

Times Pets

What Vets Wish Indian Pet Owners Knew About Pet Nutrition ?

The Fundamentals of Feeding Your Pet:

Proper nutrition results in a shiny coat, strong immunity, and an active lifestyle in pets.

When you bring your pet in for a check-up, your vet is doing a visual and hands-on assessment, and it all boils down to one thing: Is this diet…

The Conversation

FDA’s abrupt flip-flop on Moderna’s mRNA flu shot highlights growing risks to drug-makers of investing in vaccines

The Food and Drug Administration’s decision, made public on Feb. 10, 2026, to not review an application to approve Moderna’s proposed mRNA-based flu vaccine set off a firestorm of criticism from public health experts.

The Independent UK

FDA issues urgent recall of trendy supplement after three people fall ill in US

Three people with salmonella infections said they had taken the supplements

The Independent UK

FDA will drop two-study requirement for new drug approvals, aiming to speed access

The Food and Drug Administration plans to drop its longtime standard of requiring two rigorous studies for new drug approvals

Barchart

Moderna Jumps Above 20-Day Moving Average on FDA Flu Vaccine Review. Should You Buy MRNA Stock Here?

Moderna shares extend gains as FDA reverses its refusal-to-file decision on the firm’s influenza vaccine. Here’s why MRNA shares still aren’t attractive to own in 2026.

The Guardian - US

FDA reverses course and will review Moderna’s mRNA-based flu vaccine

US drug regulator originally refused to consider application, fueling critics’ concern about alleged ‘anti-vaccine agenda’

1 … 4 5 6 7

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

336 stories

Imperial College London

296 stories

Agency

276 stories

Health and Human Services

266 stories

MRNA

214 stories

the Food and Drug Administration

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.